Labcorp Selects Medidata’s Sensor Cloud to Expand Decentralized Clinical Trial Capabilities, Enabling First-in-Kind Industry Partnership for Digital Biomarker Discovery

September 14, 2021

NEW YORK–(BUSINESS WIRE)–Sep 13, 2021– Medidata, a Dassault Systèmes company, and Labcorp Drug Development , a global company providing clinical laboratory and end-to-end drug development services, today announced they have entered into an agreement using the Medidata Sensor Cloud .

Read the source article at businesswire.com
2021-09-13 01:00:00

Share This Story!